Clinical Trials Logo

Clinical Trial Summary

DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.


Clinical Trial Description

DISSECT-N is a prospective, observational, global, multi-center, post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04267055
Study type Observational [Patient Registry]
Source Medtronic Cardiovascular
Contact
Status Active, not recruiting
Phase
Start date June 25, 2020
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06270537 - Post-market Clinical Trial of the Dominus® Stent-Graft
Completed NCT00597870 - Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions N/A
Recruiting NCT05639400 - Thoraflex Hybrid and Relay Extension Post-Approval Study
Completed NCT05771831 - Thrombosomes® in Acute Thoracic Aortic Dissections Phase 2
Completed NCT05414318 - CTAG Dissection/Trauma Post Marketing Surveillance Japan
Active, not recruiting NCT05610462 - Trial of Exercise in Aortic Dissection Survivors N/A
Recruiting NCT05309707 - ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"
Recruiting NCT06336213 - Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients N/A
Enrolling by invitation NCT03767777 - Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY(PATENCY) N/A
Enrolling by invitation NCT05155956 - Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
Recruiting NCT03440697 - Pathogenetic Basis of Aortopathy and Aortic Valve Disease